Mariner’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $868K | Sell |
15,701
-930
| -6% | -$51.4K | ﹤0.01% | 1901 |
|
2025
Q1 | $804K | Sell |
16,631
-1,352
| -8% | -$65.4K | ﹤0.01% | 1839 |
|
2024
Q4 | $694K | Buy |
17,983
+2,004
| +13% | +$77.4K | ﹤0.01% | 1912 |
|
2024
Q3 | $719K | Buy |
15,979
+3,696
| +30% | +$166K | ﹤0.01% | 1859 |
|
2024
Q2 | $426K | Sell |
12,283
-441
| -3% | -$15.3K | ﹤0.01% | 2167 |
|
2024
Q1 | $368K | Buy |
12,724
+3,470
| +37% | +$100K | ﹤0.01% | 2268 |
|
2023
Q4 | $212K | Sell |
9,254
-5,288
| -36% | -$121K | ﹤0.01% | 2647 |
|
2023
Q3 | $243K | Buy |
14,542
+3,708
| +34% | +$61.9K | ﹤0.01% | 2345 |
|
2023
Q2 | $299K | Sell |
10,834
-3,238
| -23% | -$89.4K | ﹤0.01% | 2119 |
|
2023
Q1 | $324K | Buy |
14,072
+3,423
| +32% | +$78.8K | ﹤0.01% | 2008 |
|
2022
Q4 | $116K | Sell |
10,649
-2,458
| -19% | -$26.8K | ﹤0.01% | 2488 |
|
2022
Q3 | $110K | Buy |
+13,107
| New | +$110K | ﹤0.01% | 2184 |
|